Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYH2085 in Chinese Adult Participants With Uncomplicated Influenza
NCT07798193Phase 2Not yet recruiting
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Oct 2026
- Primary completion
- Apr 2027
01
Overview
Phase 2, randomised, double-blind trial of SYH2085 in influenza (3 arms), sponsored by CSPC ZhongQi Pharmaceutical Technology. Primary endpoint: Time to resolution of all influenza symptoms. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
SYH2085
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07798193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07798193.